Balance Sheet

v3.10.0.1
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
Sep. 30, 2018
Mar. 31, 2018
Current Assets    
Cash $ 6,924 $ 60,934
Accounts receivable, net of allowance of nil and $2,227 at September 30, 2018 (unaudited) and March 31, 2018, respectively 11,065 12,386
Inventory 51,672 29,074
Prepaids and other current assets 54,455 124,455
Total Current Assets 124,116 226,849
Property and equipment, net 3,855 4,441
Equity investments 873,300 468,537
Other asset 5,500 5,500
TOTAL ASSETS 1,006,771 705,327
Current Liabilities    
Accounts payable 39,749 21,846
Convertible note payable, net of debt discount of $85,890 at September 30, 2018 78,610
Accrued expenses 238,029 14,039
Total Current Liabilities 356,388 35,885
Stockholders' Equity    
Preferred stock; $0.00001 par value; 5,000,000 shares authorized; none issued and outstanding at September 30, 2018 (unaudited) and March 31, 2018
Common stock; $0.00001 par value; 200,000,000 shares authorized; 10,677,110 and 10,499,610 issued and outstanding at September 30, 2018 (unaudited) and March 31, 2018, respectively 107 105
Additional paid in capital 3,538,900 3,054,297
Common stock to be issued, 212,000 and 263,000 shares at September 30, 2018 (unaudited) and March 31, 2018, respectively 537,852 526,000
Accumulated deficit (3,407,857) (2,901,933)
Total Applied BioSciences Corp. Stockholders' Equity 669,002 678,469
Non-controlling interest (18,619) (9,027)
Total Stockholders' Equity 650,383 669,442
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 1,006,771 $ 705,327

Source